New Nimodipine Formulation Aimed At Reducing Fatal Medication Errors
This article was originally published in The Pink Sheet Daily
Executive Summary
Nymalize, an oral formulation of brain hemorrhage treatment nimodipine, aims to minimize serious risks associated with incorrect administration of older forms of the drug.
You may also be interested in...
Edge 'Devastated' By Phase III Failure of EG-1962, Set To Downsize
Company announces plans for layoffs after Phase III NEWTON 2 study of EG-1962 for subarachnoid hemorrhage goes up in smoke.
FDA's Drug Safety Oversight Board Looks To Promote Its Value
FDA's Drug Safety Oversight Board is trying to promote its value to the medical and regulatory communities by highlighting its role in addressing postmarketing safety issues
PhRMA’s Vision For 21st Century Marketing Would Reshape Supplemental NDAs
Five-point plan that calls for FDA to change definition of ‘labeling’ and ‘substantial evidence’ may offer hints as to what the next iteration of 21st Century Cures legislation will offer.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: